Table 2.

Cardiovascular markers across oral contraceptive phases in group VLD and group LD

	Group VLD (n=11)			p value	Group LD (n=11)		p value
	Active	EE	Pill-free		Active	Pill-free
HDL, mg/dL	56±4	63 ±4	58±5	.082	56±2	58±3	.129
LDL, mg/dL	90±6	99±9	106±7*	.039	100±6	117±6	.004
TC, mg/dL	170±9	182±	186±11	.099	175±6	191±7	.006
TRG, mg/dL	119±15	100±18	109±20	.428	96±9	80±9	.028
TC/HDL ratio, mg/dL	3.1±0.1	2.9±0.1	3.3±0.2†	.017	3.2±0.2	3.4±0.2	.012
hs-CRP, mg/L	3.88±0.75	3.74±0.91	2.72±0.97	.474	2.29±0.40	1.94±0.40	.203
Coronary risk index	2.0±0.1	1.9±0.2	1.9±0.3	.817	2.1±0.5	2.5±0.5	.349
Blood pressure, mmHg
Systolic	116±2	118±3	117±2	.648	109±2	111±2	.151
Diastolic	75±2	76±2	78±2	.074	69±1	70±2	.503
Mean arterial	88±2	90±2	91±2	.292	83±1	84±2	.300
Heart rate, bpm	64±3	62±3	63±3	.081	60±3	61±2	.352

Values are means±SE.

^*p=.039 vs. active.

^†p=.017 vs. EE.